Pulmatrix Registers Resale of Common Stock Issuable Upon Conversion and Dividend of Series B Preferred Stock

Filing content

The company filed a prospectus for the resale of up to 491,607 shares of common stock issuable upon the conversion and dividend payment of its Series B convertible preferred stock issued in March 2026.